Home pharmacy care program in community pharmacy to improve outcome of hypertension: A quasi-experimental study 10.55131/jphd/2026/240205

Main Article Content

Dewa Ayu Putu Satrya Dewi
Putu Yudhistira Budhi Setiawan
Ni Putu Aryati Suryaningsih

Abstract

Home Pharmacy Care (HPC) is a program implemented by the Ministry of Health of the Republic of Indonesia to deliver the highest quality healthcare services to individuals dealing with degenerative conditions, such as hypertension.  This study sought to assess the efficacy of HPC interventions in hypertensive patients in Denpasar, Bali, Indonesia.  From March to June 2024, this investigation implemented a quasi-experimental pre- and post-design with control in a community pharmacy.  A randomized sampling technique was employed to select 100 patients with uncontrolled hypertension, who were distributed into two groups.  The intervention group was provided with HPC, which consisted of a medication reminder card, education on hypertension, home blood pressure monitors, and hypertension control. Patients in the control group received standard care. ³It was found that the decrease in SBP in intervention group D±SD 13.06 ± 6.14 was better than control group D±SD 3.32 ± 5.35, while DBP intervention group D±SD 7.64 ± 4.25 was better than control group D±SD 5.06 ± 4.69. The effect of HPC on blood pressure showed a significant difference (P=0.00), and 56% of the patients in the HPC group had controlled BP. Our study demonstrated that the implementation of HPC in community pharmacies for hypertensive patients can significantly aid them in managing their blood pressure, thereby reducing the cardiovascular risks associated with hypertension.  Additionally, the potential to improve patient satisfaction with pharmacist-provided care exists through the effective implementation of HPC.

Article Details

How to Cite
1.
Satrya Dewi DAP, Putu Yudhistira Budhi Setiawan, Ni Putu Aryati Suryaningsih. Home pharmacy care program in community pharmacy to improve outcome of hypertension: A quasi-experimental study: 10.55131/jphd/2026/240205. J Public Hlth Dev [internet]. 2026 May 8 [cited 2026 May 10];24(2):73-85. available from: https://he01.tci-thaijo.org/index.php/AIHD-MU/article/view/278871
Section
Original Articles
Author Biographies

Dewa Ayu Putu Satrya Dewi, Department of Clinical Pharmacy, Faculty of Health Sciences, Universitas Bali Internasional, Indonesia

Department of Clinical Pharmacy, Faculty of Health Sciences, Universitas Bali Internasional, Indonesia

Putu Yudhistira Budhi Setiawan, Department of Clinical Pharmacy, Faculty of Health Sciences, Universitas Bali Internasional, Indonesia

Department of Clinical Pharmacy, Faculty of Health Sciences, Universitas Bali Internasional, Indonesia

Ni Putu Aryati Suryaningsih, Department of Clinical Pharmacy, Faculty of Health Sciences, Universitas Bali Internasional, Indonesia

Department of Clinical Pharmacy, Faculty of Health Sciences, Universitas Bali Internasional, Indonesia

References

Georgianos, P.I. Agarwal, R. Hypertension in chronic kidney disease-treatment standard 2023. NDT. 2023;38:2694–2703. DOI: 10.1093/ ndt/gfad118

Naha S, Gardner MJ, Khangura D, et al. Hypertension in Diabetes: MDTex. com. 2000

Sulistiawati S, Dewanti L, Pratama AP, Atika A, Fatmaningrum W, Nuswantoro D, et al. Profile and lifestyle of hypertensive patients, cardiovascular comorbidity, and complications in a primary health center in Surabaya, Indonesia. MJMS. 2020;8:219–23. doi:10.3889/oamjms. 2020.4432

WHO. World health statistics 2022 (Monitoring health of the SDGs). 2022;

Kemenkes. Laporan Nasional Riset Kesehatan Dasar. Jakarta; 2019.

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;6:1105–87 doi: 10.1097/HJH.0b013e3281fc975a

Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs a systematic review and meta-analysis. Medicine. 2017;96(4):1-9doi: 10.1097/MD.0000000000005641

Salamah S, Khafiyya AN, Ramadhani R, Arfiana MR, Syamsuri I, Faizah NN, et al. Outcomes of the Indonesian Chronic Disease Management Program (Prolanis) in Patients with Hypertension During the COVID-19 Pandemic in Rural Areas: A Preliminary Evaluation Study. MSM. 2023;29. doi: 10.12659/MSM.939797

Widyastuti S, Yasin NM, Kristina SA. Pengaruh Home Pharmacy Care Terhadappengetahuan, Kepatuhan, Outcome Klinik dan Kualitas Hidup Pasien Hipertensi. Maj Farmaseutik. 2019;15(2):105-112. doi:10.22146/ farmaseutik.v15i2.47623

Utaminingrum W, Lestari JE, Kusuma AM. Pengaruh Faktor-Faktor Sosiodemografi Terhadap Rasionalitas Penggunaan Obat Dalam Pengobatan Sendiri Pada Pasien Program Pengelolaan Penyakit Kronis (Prolanis). Farmasains. 2015;2(6):285–8.

Abate E, Antrobus C, Diamandis S, Drayton A, Johnston S, Lim L, et al. Practice Guidelines for pharmacists providing immunisation services. 2020.

DepKes RI DBFK dan K. Pedoman Pelayanan Kefarmasian di Rumah (Home Pharmacy Care). 2008;1–37.

Zhang S, Qi DZZ, Tian L, Qian S, Song D, Chen B, et al. Effects of home medication review on drugrelated problems and health-related quality of life among community-dwelling older adults in China. JAPhA. 2022;62(2): 481-486 doi: 10.1016/j.japh.2021. 10.023

Abu Fadaleh SM, Charrois TL, Makhinova T, Eurich DT, Rahman S, Sadowski CA. The effect of home medication review in community-dwelling older adults: a systematic review. J Public Health. 2022;30(8): 1857–72. doi:10.1007/s10389-020-01447-0

Gudi SK, Kashyap A, Chhabra M, Rashid M, Tiwari KK. Impact of pharmacist-led home medicines review services on drug-related problems among the elderly population: A systematic review. EPIH. 2019;41:1–9. doi: 10.4178/epih.e2019020

Ang WC, Che Lah J, Zulkepli N, Sukri N, Rosedi A. Carers’ perspectives on home medication review by a state hospital in Malaysia. IJCS. 2022;5(1): 49–55.doi: 10.31436/ijcs.v5i1.236

Hasanah L, Fitriyah N, Sari RNP, Prayoga D. Factors influencing community decisions in choosing community health centers for promotive and preventive health services: literature review. MPPKI. 2024;7(7):1797–803. doi: 10.56338/ mppki.v7i7.5122

Wal P, Wal A, Bhandari A, Pandey U, Rai A. Pharmacist involvement in the patient care improves outcome in hypertension patients. JRPP. 2013; 2(3):12-129. doi: 10.4103/2279-042X.122386

Rikmasari Y, Munarsih E, Alfionita H, Pharmacy DC, Administrative SB, Ilmu ST, et al. Adherence and clinical outcomes of hypertensive patients in rural areas after receiving home pharmacy care interventions. JPS. 2024;26(April):117–23. doi: 10.56064/ jps.v26i1.947

Thiruchelvam K, Byles J, Hasan SS, Egan N, Kairuz T. Home medicines review and frailty among community-dwelling older women. IJPP. 2021;29(6):548–55. doi: 10.1093/ijpp/ riab054

Kemenkes. Petunjuk Teknis StandarPelayananKefarmasian di Puskesmas. 2019;

Utaminingrum W, Pranitasari R, Kusuma AM. Effect of Pharmacist Home Care on Adherence of Hypertensive Patients. IJCP. 2017;6(4): 240–6. doi: 10.15416/ijcp.2017.6.4.240

Utami P, Rahajeng B, Soraya C. Pengaruh edukasi home pharmacy care terhadap kualitas hidup pasien hipertensi di puskesmas. J Farm Sains dan Prakt. 2019;5:141–51.doi: 10.31603/pharmacy.v5i1.2625

Artiyaningrum B, Azam M. Faktor-faktor yang berhubungan dengan kejadian hipertensi tidak terkendali pada penderita yang melakukan pemeriksaan rutin. Public Health Perspect. J. 2016;1(1):12–20.

Calisanie NNP, Susanti S, Lindayani L. Cardiovascular Risk Estimation in Patients with Hypertension: A Cross-Sectional Study. JNERS. 2020;15(1): 98–104. doi: 10.20473/jn.v15i1.16262

Newman T V., San-Juan-Rodriguez A, Parekh N, Swart ECS, Klein-Fedyshin M, Shrank WH, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: an umbrella review. RSAP. 2020;16(9):1155–65. doi: 10.1016/j.sapharm.2019.12.016

Reeves L, Robinson K, McClelland T, Adedoyin CA, Broeseker A, Adunlin G. Pharmacist Interventions in the Management of Blood Pressure Control and Adherence to Antihypertensive Medications: A Systematic Review of Randomized Controlled Trials. J Pharm Pract. 2021;34(3):480–92. doi: 10.1177/0897190020903573

Athiyah U, Rahem A, Setiawan CD, Hermansyah A. Role of pharmacist in providing drug information and education for patients with chronic diseases during transition of care. Pharm Edu. 2021;21(2):275–80. doi:10.46542/pe.2021.212.275280

Daud R, Zulkarnain BS, Amu I V. Providing counseling through home pharmacy care (HPC) for hemodialysis patients with hypertension in lowering blood pressure. JBCPP. 2021;32(4): 459–65. doi: 10.1515/jbcpp-2020-0462

Ampofo AG, Khan E, Ibitoye MB. Understanding the role of educational interventions on medication adherence in hypertension: A systematic review and meta-analysis. Heart Lung. 2020;49(5):537–47. doi: 10.1016/ j.hrtlng.2020.02.039

Sholikatin WZ, Wahyuni ED, Rachmawati PD. Hypertension patients’ adherence in chronic disease care program at public health center. Int J PsychosocRehabil. 2020;24(2):4132–9. doi: 10.61841/h1mk3709

Damayanti R, Sabar S, Lestari A, Nurarifah N, Sukmawati S. Pengaruh Pemberian Edukasi Terhadap PerubahanTekanan Darah Pada Lansia Dengan Hipertensi. LentoraNurs. J. 2022;2(2):64–9. doi:10.33860/lnj. v2i2.1337

Khomaini A, Setiati S, Lydia A, Dewiasty E. Pengaruh Edukasi Terstruktur dan Kepatuhan Minum Obat Antihipertensi terhadap Penurunan Tekanan Darah Pasien Hipertensi Usia Lanjut: Uji Klinis AcakTersamar Ganda. JPDI. 2017; 4(1):4-10. doi: 10.7454/jpdi.v4i1.106

Rosli MR, Neoh CF, Wu DB, Hassan NW, Mahmud M, Rahimi A, et al. Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: A randomised controlled trial. Pharm Pract (Granada). 2021;19(3):1–13. doi: 10.18549/PharmPract.2021.3.2397